RIVN vs STRO · rev $5.39B vs rev $62.0M
Rivian Automotive Inc (RIVN) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Rivian Automotive Inc (RIVN) is a auto manufacturers company listed on NASDAQ. It is led by RJ Scaringe.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported RIVN revenue for 2025-12-31 was $5.39B. Net income was -$3.65B. Revenue was up 8.4% from 2024-12-31 to 2025-12-31. RIVN currently screens at market cap $21.81B.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
RIVN currently screens at market cap $21.81B. STRO currently screens at market cap $470.8M.
Not investment advice. Open the RIVN and STRO stock pages for the full models.
Not investment advice.